Elite Pharmaceuticals Inc (ELTP)

[Hike]

Phentermine:
Elite’s revenue derived from phentermine 37.5mg tablets during the three months ended June 30, 2012 and 2011 were approximately $162k and $217k, respectively, with such amounts including manufacturing revenues, royalties and a $145k milestone payment triggered by the shipment of the product in April 2011.

Take the 145k out of the 2011 number they went from 72k to 217k


Lodrane:
Elite’s revenue derived from Lodrane D® during the three months ended June 30, 2012 and 2011 were approximately $142k and zero, respectively.

Methadone:
Elite’s revenues derived from the contract manufacture of Methadone 10mg tablets during the three months ended June 30, 2012 and 2011 were approximately $128k and zero, respectively.


Hydromorphone:
Elite’s revenues derived from Hydromorphone 8mg tablets during the three months ended June 30, 2012 and 2011 were approximately $78k and zero, respectively, with such amounts including manufacturing revenues and royalties paid pursuant to the Precision Dose Agreement.

All combined they went from: 72k to 565k (In one quarter) on these four items since last year.